Literature DB >> 1301188

Partial gene duplication as a cause of human disease.

X Hu1, R G Worton.   

Abstract

Tandem duplication of large regions of DNA, including duplication of whole genes, provides a substrate for genetic evolution. Tandem duplication of smaller regions involving parts of genes is now recognized as a contributor to the mutation spectrum that results in genetic disease. In this review, more than 30 unrelated partial gene duplications that have been implicated in the genesis of human genetic disease are presented and the pathogenic effects and frequency of such duplications are summarized. The mechanisms of duplication formation are analyzed with special emphasis on the molecular details of the nucleotide sequences at the duplication junctions. Evidence to date suggests that duplication may arise from either homologous (Alu-Alu) recombination or nonhomologous recombination, the latter possibly mediated by topoisomerases. For the dystrophin gene, in which most duplications have been identified, these recombination events are intrachromosomal, suggesting that unequal sister chromatid exchange is the major mechanism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1301188     DOI: 10.1002/humu.1380010103

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

1.  Instability of repetitive DNA sequences: the role of replication in multiple mechanisms.

Authors:  M Bzymek; S T Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  Ubiquitous internal gene duplication and intron creation in eukaryotes.

Authors:  Xiang Gao; Michael Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-19       Impact factor: 11.205

3.  Slipped misalignment mechanisms of deletion formation: in vivo susceptibility to nucleases.

Authors:  M Bzymek; C J Saveson; V V Feschenko; S T Lovett
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

4.  Duplication of seven exons in the lysyl hydroxylase gene is associated with longer forms of a repetitive sequence within the gene and is a common cause for the type VI variant of Ehlers-Danlos syndrome.

Authors:  J Heikkinen; T Toppinen; H Yeowell; T Krieg; B Steinmann; K I Kivirikko; R Myllylä
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

5.  Enhanced deletion formation by aberrant DNA replication in Escherichia coli.

Authors:  C J Saveson; S T Lovett
Journal:  Genetics       Date:  1997-06       Impact factor: 4.562

6.  Partial duplication of the CRYBB1-CRYBA4 locus is associated with autosomal dominant congenital cataract.

Authors:  Owen M Siggs; Shari Javadiyan; Shiwani Sharma; Emmanuelle Souzeau; Karen M Lower; Deepa A Taranath; Jo Black; John Pater; John G Willoughby; Kathryn P Burdon; Jamie E Craig
Journal:  Eur J Hum Genet       Date:  2017-03-08       Impact factor: 4.246

7.  Deletion (X)(q26.1-->q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions.

Authors:  A T Tharapel; K P Anderson; J L Simpson; P R Martens; R S Wilroy; J C Llerena; C E Schwartz
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

8.  Human amiloride-sensitive epithelial Na+ channel gamma subunit promoter: functional analysis and identification of a polypurine-polypyrimidine tract with the potential for triplex DNA formation.

Authors:  S D Auerbach; R W Loftus; O A Itani; C P Thomas
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

9.  Stabilization of perfect and imperfect tandem repeats by single-strand DNA exonucleases.

Authors:  Vladimir V Feschenko; Luis A Rajman; Susan T Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

10.  Alu-Alu recombination results in a duplication of seven exons in the lysyl hydroxylase gene in a patient with the type VI variant of Ehlers-Danlos syndrome.

Authors:  B Pousi; T Hautala; J Heikkinen; L Pajunen; K I Kivirikko; R Myllylä
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.